Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major cancer types, we're translating cutting-edge science into market-shaping impact. Here, you'll partner with exceptional colleagues across scientific, medical, and manufacturing teams, backed by advanced digital and AI-enabled infrastructure and the authority to accelerate medicines from discovery to delivery. Guided by our values of courage, excellence, equity, and joy, you'll have the opportunity to stretch your skills and build a career that evolves with you—across teams, roles, and the Pfizer enterprise. Join us to make history — for patients, for their families, for the future.
What You Will Achieve
The US Hematology Thought Leader Engagement Lead (TLEL), will play a critical role on the growing US Hematology team by developing and executing an overarching Thought Leader engagement plan for key national and regional thought leaders in the field of Hematology. Pfizer’s Hematology portfolio spans multiple products in lymphoma, multiple myeloma and leukemia. This leader will create a first-class experience for external stakeholders in Hematology, coordinating relationships end-to-end (research to end-of-lifecycle) and working as part of a broader cross-functional Pfizer team. Focusing on National, Emerging, and certain Community Thought Leaders, this person will be responsible for establishing and maintaining relationships across a wide variety of key Hematology thought leaders.
The TLEL will be engaging Hematology Thought Leaders via 1:1 engagements at major congresses and national / regional product theaters to identify mutual points of interest between the TL and Pfizer Oncology Commercial, gathering insights on Hematology Thought Leader beliefs and preferences to inform development and execution of HCP commercial strategies / tactics, nominating TLs for Ad Boards, Speaker Programs, or other programming as requested by marketing teams, collaborating effectively with the HEME Global Thought Leader Strategy Lead, and advancing the capabilities of the Hematology franchise in the US.
ROLE RESPONSIBILITIES
Develop, in partnership with key functions within the commercial team, a ONE Pfizer approach that fully integrates Opinion Leader and key stakeholder engagement plans inclusive of HCPs, Opinion Leaders and researchers to maximize the evolving Pfizer Hematology portfolio in the US.
• Drive a ONE Pfizer, fully integrated approach to engaging HCPs, opinion leaders, and researchers to maximize the US Hematology portfolio
• Partner with cross-functional stakeholders (Marketing, Medical, Key Account Teams, Policy, Patient Affairs, Communications) to align engagement strategies with business priorities
• Gather and synthesize insights from 1:1 engagements, small group interactions, advisory boards, and congress activities to inform portfolio strategy and decision-making
• Translate stakeholder insights into actionable recommendations to support commercial execution and strategic planning
• Develop and maintain comprehensive Opinion Leader and key stakeholder engagement plans, including tracking of interactions and outcomes
• Facilitate connections between opinion leaders and internal subject matter experts to support appropriate engagement and collaboration
• Coordinate and support execution of speaking engagements, including symposia and speaker programs
• Design, implement, and manage engagement metrics, including post-engagement evaluations, congress feedback, and benchmark surveys
• Ensure all engagement activities and processes adhere to Pfizer legal, compliance, and regulatory standards
• Conduct local
Apply on employer site ↗